Experimental vaccine gives father of the bride precious time

Almost a year to the day after learning he had the deadliest form of brain cancer, Steve Holl was dancing at his daughter Eryn's wedding.

"To have my dad there was just one of those moments where you really want to stop time," Eryn Holl says. "You want to look at him and hold on tight."

Fewer than one in three patients with Holl's type of cancer, a glioblastoma, have traditionally survived a year, let alone been well enough to dance.

But Holl, 61, has something going for him beyond radiation and chemotherapy -- a custom-made vaccine.

Holl (pronounced Hall) received the vaccine as part of a clinical trial at the University of California San Francisco.

"The approach that we take is we actually do the surgery. We take the tumor out, and then we make the vaccine directly from that individual patient's tumor. And then give that vaccine back to the patient," says Dr. Andrew Parsa, who heads the trial.